Forecast: Production of Chemical and Pharmaceutical Products in Sweden

Production of chemical and pharmaceutical products in Sweden has experienced significant fluctuations over the past decade. From 2013 to 2016, there were modest declines and sporadic growth, followed by a consistent upward trend starting in 2017. Particularly noteworthy are the sharp increase of 35.47% in 2021 and a significant decrease of 19.46% in 2020. By 2023, production stood at 209.76 billion Swedish Kronas, recording a year-on-year growth of 2.04%. Over the past five years, the CAGR has been 4.53%, indicating overall positive growth. Looking forward, projections suggest a steadier growth trend with a 5-year CAGR of 1.54% from 2024 to 2028.

Future trends to watch for:

• Potential impact of environmental regulations on production processes.
• Advancements in biotechnology and their influence on pharmaceutical output.
• Effects of global supply chain disruptions on Swedish production capabilities.
• Increased investment in research and development driving innovation.